Germline <i>PALB2</i> Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients
The prevalence of the <i>PALB2</i> mutation in breast cancer varies across different ethnic groups; hence, it is of intense interest to evaluate the cancer risk and clinical association of the <i>PALB2</i> mutation in Chinese breast and/or ovarian cancer patients. We performe...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/16/4195 |